Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
Low
19.10
High
19.90
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BELLUS Health Inc | BLU | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 19.48 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 19.48 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 19.10 - 19.90 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 19.48 | CAD |
BELLUS Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.47B | - | - | - | -9,838.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BELLUS Health News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/28/2023 | 09:59 | PR Newswire (Canada) | Annonce boursière - Réservée aux médias et aux investisseurs.. |
| 6/28/2023 | 09:57 | PR Newswire (Canada) | Stock-exchange announcement - For media and investors only -.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLU Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 19.69 | 19.90 | 19.10 | 19.57 | 48,475 | -0.21 | -1.07% |
| 3 Years | 5.25 | 19.90 | 3.32 | 10.85 | 110,292 | 14.23 | 271.05% |
| 5 Years | 1.35 | 19.90 | 1.10 | 7.73 | 141,463 | 18.13 | 1,342.96% |
BELLUS Health Description
| BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has... |
